Perceived stress and monetary burden among thalassemia patients and their caregivers

Aliya Hisam, Najm Us Sadiq Khan, Naseer Alam Tariq, Hira Irfan, Bushra Arif, Mawra Noor, Aliya Hisam, Najm Us Sadiq Khan, Naseer Alam Tariq, Hira Irfan, Bushra Arif, Mawra Noor

Abstract

Objective: To find the perceived stress level and monetary burden in the thalassemia patients and their caregivers related to thalassemia treatment sessions.

Methods: A descriptive cross sectional study was conducted at Rawalpindi Thalassemia Centre and Military Hospital Rawalpindi of six months' duration from November 2016 to April 2017. A total of 87 sample size was calculated by using WHO sample size calculator. Participants were inducted through purposive sampling technique from thalassemia centers. A validated standardized Cohen's Perceived Stress score was used. Data were entered and analyzed in SPSS 22.

Results: Mean age of the participants was 30.42 ± 14.53 years. There were 30 (34.2%) males and 57 (65.8%) females. There were 39 (51.3%) patients and 48 (48.7%) caregivers. The mean income per month of the participants was 48706.9 ± 39492.68 PKR. The mean total expenditure per treatment session was 48706 ± 4037.12 PKR. Among the patients, there were 15 (38.5%) who were having average stress, while 4 (10.3%) were having moderate stress while 45 (51.7%0 were having severe stress. Among the caregivers, 10 (20.8%) were having mild stress, 13 (27.1%) were having moderate stress while 25 (52.1%) were having severe stress. The stress among the two groups was not statistically significant (p=0.066).

Conclusion: More than half of the patients and caregivers were having a high perceived stress levels and there was a significant association between the two groups. The monetary burden was a lot to bear by the patients and the cost of treatment session most expensive.

Keywords: Caregivers; Cost; Monetary burden; Patients; Psychological burden; Stress; Thalassemia.

Figures

Fig.1
Fig.1
Stress among thalassemia patients and their caregivers (n=87) (p=0.066)**
Fig.2
Fig.2
Perceived stress score among thalassemia patients and their caregivers (p=0.006)*

References

    1. John PG, Daniel AA, Bertil G, Alan F. Wintrobe's Clinical Hematology. 13th Edition. United States: 2013.
    1. Vinay K, Abbas AK, Jon CA, Robbins, Cotran Pathological Basis of Disease. (9th Edition) 2015
    1. Ferrier DR. Lippincott's Illustrated Reviews:Biochemistry. (6th Edition) 2014
    1. World Health Organization. Genomic resource center:Genes and human disease. [Cited on Dec 2016]. Available from: .
    1. Smith Y. Thalassemia Prevalence. [Updated on August 2015. Cited on December 2015]. Available from .
    1. Thalassemia Federation of Pakistan 2016. Lahore. [Cited Dec 6 2016]. Available from:
    1. Ansari SH, Shamsi TS, Ashraf M, Bohray M, Farzana T, Khan MT, et al. Molecular epidemiology of β-thalassemia in Pakistan:far reaching implications. Int J Molecular Epidemiol Genet. 2011;2(4):403.
    1. Borgna PC, Rugolotto S, Stefano PD, Zhao H, Cappellini MD, Vecchio GCD, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
    1. Chern JPS, Su S, Lin KH, Chang SH, Lu MY, Jou ST, et al. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan. Pediat Blood Cancer. 2007;48(5):550–554. doi:10.1002/pbc.21028.
    1. American Psychological Association. Understanding Chronic Stress. [Cited on 2017 5 April]. Available from: .
    1. Zaheer Z, Wazir S, Hameed B, Zeeshan S, Zaman Q, Iqbal M. Psychological burden in β-thalassemia affected families. J Postgrad Med Inst. 2015;29(4):260–263.
    1. Cohen Perceived Stress. Available from: .
    1. Mazzone L, Battaglia L, Andreozzi F, Romeo MA, Mazzone D. Emotional impact in β-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers. Clin Pract Epidemiol Mental Health. 2009;5(1):5. doi:10.1186/1745-0179-5-5.
    1. Wu HP, Lin CL, Chang YC, Wu KH, Lei RL, Peng CT, et al. Survival and complication rates in patients with thalassemia major in Taiwan. Pediat Blood Cancer. 2017;64(1):135–138. doi:10.1002/pbc.26181.
    1. Sherief LM, Dawood O, Ali A, Sherbiny HS, Kamal NM, Elshanshory M, et al. Premature atherosclerosis in children with beta- thalassemia major:New diagnostic marker. BMC Pediat. 2017;17(1):69. doi:10.1186/s12887-017-0820-1.
    1. Ali S, Sabih F, Jehan S, Anwar M, Javed S. Psychological distress and coping strategies among parents of beta-thalassemia major patients. Int Conf Clean Green Energy. 2012;27:124–128.
    1. Aziz K, Sadaf B, Kanwal S. Psychosocial problems of Pakistani parents of Thalassemic children:a cross sectional study done in Bahawalpur, Pakistan. Biopsychosoc Med. 2012;6(1):15. doi:10.1186/1751-0759-6-15.
    1. Lyrakos GN, Drossou-Servou M, Vini D, Aslani H, Spinaris V. 1467–Symptoms of depression, anxiety and stress in patients with thalassemia in a greek transfusion center. Eur Psych. 2013;28:1. doi:10.1016/S0924-9338(13)76495-2.
    1. Khanna AK, Prabhakaran A, Patel P, Ganjiwale JD, Nimbalkar SM. Social, Psychological and Financial Burden on Caregivers of Children with Chronic Illness:A Cross-sectional Study. Ind J Pediatr. 2015;82(11):1006–1011. doi:10.1007/s12098-015-1762-y.
    1. Khamoushi F, Ahmadi SM, Karami MB, Ahmadi JT, Mirzaei AM, Ataee M, et al. Prevalence and Socio-Demographic Characteristics Related to Stress, Anxiety, and Depression among Patients with Major Thalassemia in the Kermanshah County. J Biol Todey's World. 2015;4(3):79–84. doi:10.15412/J.JBTW. 01040304.
    1. Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E, et al. Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disord. 2012;12(1):6. doi:10.1186/1471-2326-12-6.
    1. Ishfaq K, Naeem SB, Ali J. Socio-economic factors of thalassemia major on patients'families:a case study of the Children's hospital and the Institute of Child Health Multan, Pakistan. Int J Med Appl Health. 2013;1(1):37–41.
    1. Scalone L, Mantovani LG, Krol M, Rofail D, Ravera S, Grazia BM, et al. Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy:the ITHACA study. Current Med Res Opin. 2008;24(7):1905–1917. doi:10.1185/03007990802160834.
    1. Haghpanah S, Nasirabadi S, Ghaffarpasand F, Karami R, Mahmoodi M, Parand S, et al. Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire. Sao Paulo Me J. 2013;131(3):166–167. doi:10.1590/1516-3180.2013.1313470.
    1. Majid S, Abidi M. Quality Of Life And Coping Styles Of Care–Givers Of Patients Suffering From Thalassemia major. Int J Med Pharm Sci. 2013;3(10):41–48.
    1. Rajput AH, Nadeem F, Kumar V. Depression, Anxiety and Stress among Primary caregivers of thalassemia patients in Hyderabad. J Pak Psych Soc. 2015;12(4):36–39.
    1. Inamdar S, Inamdar M, Gangrade A. Stress Level among Caregivers of Thalassemia Patients. Community Med. 2015;6(4):579–578.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe